increas
concern
antimicrobi
resist
led
develop
implement
altern
antimicrobi
use
anim
product
object
clinic
trial
determin
effect
colostrum
supplement
milk
replac
ration
morbid
mortal
feed
intak
weight
gain
prewean
calv
nineti
calv
commerci
calf
ranch
randomli
alloc
group
treatmentgroup
calv
receiv
g
supplement
immunoglobulin
g
igg
form
g
colostrum
powder
milk
replac
twice
daili
placebogroup
calv
receiv
nutrit
equival
supplement
lack
igg
milk
replac
twice
daili
control
calv
receiv
milk
replac
without
supplement
twice
daili
calv
hous
individu
hutch
weigh
serum
collect
serum
igg
determin
daili
health
evalu
first
life
perform
studi
personnel
blind
treatment
group
assign
observ
ill
treat
base
health
assess
rectal
temperatur
specif
calf
ranch
protocol
feed
consumpt
milk
grain
record
calv
receiv
supplement
colostrum
less
diarrhea
receiv
fewer
antimicrobi
treatment
control
placebo
calv
result
indic
calf
diarrhea
associ
low
serum
igg
level
lowweight
calv
grain
consumpt
weight
gain
first
life
significantli
greater
colostrumsuppl
calv
compar
control
calv
differ
mortal
respiratori
diseas
incid
among
group
detect
supplement
colostrum
first
wk
life
reduc
diarrheal
diseas
prewean
calv
calf
ranch
therebi
reduc
amount
antimicrobi
treatment
need
concern
prophylact
metaphylact
use
antimicrobi
drug
food
anim
product
increas
antimicrobi
resist
potenti
advers
effect
human
health
faowho
oie
silbergeld
et
al
anim
agricultur
industri
encourag
reduc
use
type
antimicrobi
drug
find
nonantimicrobi
altern
nontherapeut
need
optim
anim
health
manag
approach
one
area
focu
dairi
beef
industri
calv
calf
ranch
rear
dairi
heifer
replac
bull
calv
beef
key
aspect
success
rear
anim
ensur
adequ
intak
colostrum
support
anim
passiv
immun
calv
adequ
passiv
transfer
immun
lower
mortal
morbid
fewer
antibiot
treatment
compar
anim
failur
passiv
transfer
berg
et
al
despit
gener
knowledg
import
feed
colostrum
neonat
calf
calv
arriv
calf
ranch
suboptim
serum
immunoglobulin
level
besser
et
al
besser
gay
hopkin
quigley
address
problem
wide
accept
practic
feed
antimicrobi
prewean
calv
braidwood
henri
constabl
glantz
et
al
quigley
et
al
properli
provid
support
system
immun
good
qualiti
colostrum
need
administ
appropri
volum
earli
possibl
within
first
h
birth
weaver
et
al
howev
evid
antibodi
remain
gut
lumen
colostrum
feed
also
provid
local
immun
enter
viral
infect
diarrhea
caus
bacteri
enterotoxin
may
enhanc
intestin
villu
develop
snodgrass
et
al
snodgrass
et
al
saif
bohl
buhler
et
al
given
observ
absenc
properli
administ
colostrum
possibl
colostrum
supplement
could
provid
local
gut
immun
decreas
need
supplement
antimicrobi
colostrumdepriv
calv
object
studi
multisit
clinic
trial
determin
effect
oral
igg
supplement
prewean
calf
mortal
morbid
weight
gain
feed
intak
hypothesi
oral
igg
supplement
earli
prewean
period
decreas
calf
mortal
morbid
colostrum
supplement
trial
perform
california
calf
ranch
rais
dairysourc
calv
bull
calv
rear
beef
ranch
mix
bull
beef
heifer
replac
ranch
b
bull
beef
ranch
c
studi
conduct
octob
septemb
ranch
calv
fed
milk
replac
cp
crude
fat
cf
medic
neomycin
tetracyclin
ranch
b
calv
fed
milk
replac
cp
cf
medic
neomycin
tetracyclin
first
wk
thereaft
calv
receiv
pasteur
hospit
milk
medic
tetracyclin
ranch
c
calv
fed
nonmed
milk
replac
cp
cf
ranch
standard
procedur
calv
receiv
colostrum
supplement
first
feed
usual
afternoon
follow
deliveri
ranch
calv
bottlef
l
milk
replac
milk
twice
daili
fresh
water
fresh
calf
starter
grain
bucket
administ
daili
minimum
nineti
holstein
calv
enrol
calf
ranch
randomli
alloc
treatment
group
colostrum
supplement
cs
placebo
supplement
ps
unsuppl
control
uc
assumpt
calcul
sampl
size
type
error
type
ii
error
detect
differ
mean
diarrhea
day
uc
pc
calv
compar
cs
calv
sampl
standard
deviat
estim
sampl
size
inflat
allow
loss
followup
cs
group
receiv
g
dri
colostrum
powder
calv
choic
total
bronz
saskatoon
colostrum
co
ltd
saskatchewan
canada
contain
g
igg
daili
milk
replac
meal
colostrum
powder
contain
cp
cf
lactos
ash
gross
energi
mcal
kg
dm
correspond
g
powder
ps
group
similarli
receiv
g
milk
replac
powder
match
colostrum
supplement
cp
cf
calva
product
inc
acampo
ca
contain
igg
uc
group
receiv
addit
milk
replac
formula
supplement
mix
dl
warm
water
ad
bottl
addit
milk
replac
powder
studi
personnel
charg
feed
calv
independ
evalu
daili
studi
personnel
blind
calf
treatment
group
evalu
morbid
includ
fecal
consist
attitud
hydrat
respiratori
score
berg
et
al
abnorm
note
rectal
temperatur
obtain
treatment
first
perform
record
studi
personnel
base
treatment
protocol
agre
upon
farm
manag
cours
antimicrobi
treatment
longer
accord
label
instruct
farmspecif
treatment
protocol
diarrheal
diseas
defin
wateri
andor
bloodi
fece
respiratori
score
nasal
discharg
cough
heavi
thorac
breath
abdomin
breath
respiratori
diseas
defin
score
calv
diarrhea
respiratori
diseas
treat
antimicrobi
drug
describ
calv
weigh
time
trial
mechan
scale
accuraci
nearest
lb
entri
trial
farm
wean
feed
consumpt
milk
grain
record
manag
calv
taken
calf
ranch
studi
personnel
return
measur
wean
weight
blood
sampl
calv
collect
day
arriv
ranch
ranch
blood
sampl
also
collect
evalu
colostrum
supplement
modifi
serum
igg
level
calv
serum
igg
level
determin
use
commerci
radial
immunodiffus
assay
immunocheck
vmrd
pullman
wa
health
treatment
data
record
spreadsheet
program
excel
microsoft
corp
redmond
wa
analyz
use
statist
softwar
program
version
sa
institut
inc
cari
nc
nineti
percent
confid
interv
calcul
main
effect
estim
interact
main
effect
test
retain
model
pvalu
passiv
transfer
immun
passiv
transfer
immun
statu
classifi
failur
passiv
transfer
fpt
igg
mgdl
partial
failur
passiv
transfer
pfpt
valu
mgdl
adequ
passiv
transfer
apt
igg
mgdl
tyler
et
al
berg
et
al
calf
weight
taken
calv
initi
process
arriv
ranch
classifi
low
weight
kg
lb
mid
weight
kg
lb
high
weight
kg
lb
mortal
mortal
calv
first
evalu
use
univari
kaplanmei
surviv
plot
cox
proport
hazard
model
use
multivari
assess
mortal
proportion
hazard
assess
plot
ln
surviv
ln
calfday
includ
timedepend
interact
predict
variabl
proport
hazard
model
use
linear
proportion
test
allison
hazard
rate
ratio
confid
interv
main
effect
treatment
group
covari
calf
ranch
arriv
weight
categori
serum
igg
categori
determin
hosmer
lemeshow
morbid
percentag
day
calv
diarrhea
treat
diarrhea
calcul
number
day
calf
observ
diarrhea
day
risk
condit
treatment
group
assess
use
neg
binomi
model
allison
treatment
group
main
effect
evalu
confound
variabl
includ
calf
ranch
calf
arriv
weight
categori
calf
igg
categori
day
first
antimicrobi
treatment
diarrhea
condit
treatment
group
includ
confound
variabl
evalu
use
surviv
analysi
approach
describ
previous
mortal
differ
respiratori
morbid
base
ordin
sever
scale
treatment
group
assess
use
jonckheereterpstra
nonparametr
test
trend
holland
wolf
adg
grain
intak
gener
linear
model
calcul
least
squar
mean
use
compar
treatment
differ
adg
age
wean
least
squar
mean
estim
confid
interv
calcul
main
effect
treatment
group
covari
calf
ranch
arriv
weight
categori
serum
igg
categori
grain
consumpt
measur
daili
averag
daili
intak
calcul
main
effect
covari
set
use
adg
use
evalu
grain
intak
clinic
trial
includ
calv
ranch
ranch
b
ranch
c
calv
die
obtain
blood
sampl
serum
igg
evalu
day
arriv
calv
ranch
c
exclud
studi
failur
passiv
transfer
common
studi
calv
igg
categori
fpt
pfpt
apt
respect
tabl
ranch
serum
igg
calv
significantli
differ
calv
treatment
group
data
shown
calv
categor
arriv
weight
categori
low
mid
high
tabl
mortal
rate
first
trial
ranch
b
c
respect
proport
hazard
model
indic
signific
influenc
colostrum
supplement
mortal
tabl
hazard
die
calv
fpt
pfpt
time
greater
respect
calv
apt
trial
period
overal
percentag
day
diarrhea
observ
colostrumsuppl
group
lowest
percent
tabl
differ
risk
diarrhea
placebo
supplement
unsuppl
control
calv
rel
risk
ci
calv
fpt
pfpt
increas
risk
diarrhea
compar
calv
apt
lowand
midweight
calv
also
tend
greater
risk
diarrhea
higharrivalweight
calv
overal
calv
treat
antimicrobi
primarili
diarrheal
diseas
approxim
total
studi
calfday
tabl
calv
colostrumsuppl
group
lowest
percentag
treatment
day
kaplanmei
plot
indic
signific
differ
wilcoxon
test
equal
strata
p
day
first
treatment
diarrhea
group
figur
multivari
proport
hazard
model
control
factor
similarli
show
calv
colostrum
supplement
group
signific
increas
day
antimicrobi
treatment
hazard
ratio
ci
compar
unsuppl
control
calv
tabl
risk
treat
antimicrobi
increas
lowweight
calv
compar
highweight
calv
calv
fpt
pfpt
compar
apt
calv
respiratori
diseas
includ
heavi
respir
abdomin
breath
present
observ
calfday
tabl
signific
differ
among
treatment
group
respiratori
score
p
calv
colostrum
treatment
group
significantli
greater
adg
age
calv
unsuppl
control
group
tabl
calv
fpt
significantli
lower
adg
compar
apt
calv
lowweight
calv
greater
adg
first
life
heavier
calv
calv
ranch
b
gain
weight
calv
ranch
c
wean
factor
significantli
affect
weight
gain
igg
statu
calf
ranch
tabl
averag
daili
grain
intak
first
life
greater
calv
receiv
colostrum
placebo
supplement
compar
unsuppl
calv
heavier
weight
calv
calv
pfpt
apt
compar
fpt
tabl
signific
differ
grain
consumpt
anim
ranch
studi
indic
postgutclosur
feed
colostrum
supplement
calv
effect
reduc
day
diarrhea
associ
antimicrobi
treatment
although
colostrum
supplement
effect
adequ
passiv
transfer
immun
import
predictor
calf
health
major
calv
arriv
onto
calf
ranch
fpt
pfpt
import
predictor
mortal
morbid
low
weight
gain
low
grain
intak
addit
interact
colostrum
treatment
fpt
health
outcom
furthermor
serum
igg
measur
ranch
support
previou
studi
postgutclosur
feed
colostrum
supplement
improv
passiv
system
immun
stott
et
al
therefor
critic
time
address
failur
passiv
transfer
calf
ranch
calv
within
first
h
birth
need
address
dairi
origin
detect
differ
mortal
treatment
group
consist
previ
calv
lost
followup
routin
movement
calv
within
calf
ranch
manag
chang
ranch
c
result
calv
return
sourc
farm
mo
age
ou
studi
import
factor
associ
mortal
fpt
donovan
et
al
berg
et
al
despit
effort
develop
manag
approach
amelior
neg
impact
fpt
calf
mortal
yet
find
effect
strategi
high
mortal
ranch
c
attribut
salmonellosi
outbreak
calv
period
sever
heat
stress
sever
studi
calv
ranch
c
bloodi
diarrhea
calf
pathogen
salmonella
enterica
serovar
newport
recov
fecal
sampl
ten
calv
four
calv
well
postmortem
sampl
septicem
calv
c
b
berg
person
commun
failur
success
treat
calv
diarrheal
system
diseas
like
due
interact
fpt
virul
salmonella
newport
serovar
report
calf
cow
pathogen
result
high
mortal
resist
antimicrobi
treatment
protocol
berg
et
al
colostrum
supplement
ad
calf
milk
replac
first
life
significantli
reduc
number
day
calv
diarrhea
decreas
use
therapeut
antimicrobi
calv
effect
like
due
presenc
colostr
immunoglobulin
simpli
nutrit
benefit
colostrum
effect
diarrhea
treatment
observ
placebosuppl
calv
sever
clinic
studi
demonstr
colostrum
blood
plasma
immunoglobulin
provid
local
immun
sever
pathogen
associ
calf
diarrheal
diseas
escherichia
coli
rota
viru
corona
viru
acr
arthington
et
al
crouch
et
al
igg
supplement
use
studi
pasteur
spraydri
firstday
colostrum
studi
feed
milk
replac
contain
bovin
porcin
plasma
calv
contain
dm
immunoglobulin
result
decreas
morbid
mortal
due
enter
diseas
quigley
wolf
nonigg
factor
colostrum
supplement
eg
epiderm
growth
factor
tumor
necrosi
protect
gut
mucos
growth
heal
jaeger
et
al
burrin
et
al
blum
hammon
may
also
contribut
decreas
diarrhea
comparison
feed
serumderiv
blood
plasma
contain
immunoglobulin
colostrum
colostrum
supplement
could
elucid
compon
colostrum
critic
optim
calf
gut
health
lowweight
calv
diarrhea
day
heavier
calv
studi
calv
holstein
dairi
sourc
calv
signific
differ
passiv
transfer
statu
explain
increas
diarrhea
lowweight
calv
increas
diarrhea
may
result
lowweight
calv
fed
milk
relat
bw
calv
receiv
volum
milk
replac
result
greater
fecal
output
heavier
calv
heath
et
al
increas
rate
diarrhea
ranch
b
compar
c
like
explain
greater
number
calv
ranch
c
die
acut
observ
sign
diseas
colostrumsuppl
calv
gain
weight
age
compar
control
calv
age
differ
adg
group
earli
weight
gain
differ
cs
calv
may
due
addit
nutrient
colostrum
supplement
godden
observ
increas
grain
consumpt
group
placebo
supplement
group
also
greater
grain
consumpt
compar
control
adg
significantli
differ
control
increas
grain
intak
calv
receiv
greater
level
nutrit
milk
contrast
studi
indic
increas
energi
intak
milk
replac
lead
decreas
grain
intak
prewean
calv
kuehn
et
al
drackley
greater
weight
gain
colostrumsuppl
calv
compar
placebosuppl
control
calv
may
lower
rate
morbid
diseas
caus
inflamm
result
releas
cytokin
activ
homeorhet
respons
direct
nutrient
tissu
deposit
ie
weight
gain
toward
immunolog
defens
function
colditz
adg
greater
lowweight
calv
like
calv
receiv
milk
per
kilogram
bw
heavier
calv
calv
receiv
similar
quantiti
milk
replac
regardless
arriv
weight
calv
fpt
also
lesser
weight
gain
like
decreas
nutrient
util
reduc
feed
intak
associ
diseas
calv
compar
calv
apt
colditz
signific
factor
affect
wean
weight
fpt
calf
ranch
differ
level
grain
intak
ranch
may
partli
explain
wean
weight
differ
rel
smaller
weight
gain
calv
calf
ranch
c
compar
ranch
b
may
also
due
heat
stress
drackley
although
ensur
calv
apt
signific
manag
factor
ensur
health
neonat
calv
calf
ranch
colostrum
supplement
first
wk
life
calv
effect
reduc
diarrheal
diseas
use
antimicrobi
adg
wk
age
colostrumsuppl
calv
significantli
greater
compar
control
calv
like
combin
greater
energi
intak
liquid
feed
increas
grain
intak
fewer
day
diarrhea
calf
ranch
system
need
continu
address
problem
colostrumdepriv
calv
pathogen
load
environment
stress
success
rais
calv
minim
prophylact
therapeut
antibiot
use
supplement
calv
colostrum
product
may
valuabl
tool
achiev
goal
author
would
like
thank
calf
ranch
excel
collabor
technic
assist
gratitud
katrin
newman
marla
hartman
jennif
crook
kristina
maloy
arlynn
hurtado
ana
tejeda
univers
california
davi
colostrum
supplement
provid
saskatoon
colostrum
compani
calva
product
inc
develop
produc
placebo
supplement
provid
advic
calf
nutrit
project
support
usdacsreesnifsi
integr
approach
food
safeti
project
number
california
dairi
research
foundat
center
food
anim
healthsvm
univers
california
